A not released discussion paper from the British medical agency (MHRA) reveals 130 reports of suicidality in one month from treatment with Strattera. In addition the paper tells about 766 spontaneous reports of cardiac disorders and 172 of liver injury, and about 20 completed suicides.

The Swedish Medical Products Agency (MPA) knows that Gillberg's and Lilly's clinical trial of Strattera is a catastrophe. It has nevertheless been allowed to continue.